Molecular & Genomic Testing

How Long Do Molecular — Test Results Take?

Molecular testing goes deeper than the standard biopsy report, and the wait is longer — often much longer. Most patients are not told this before the test is ordered, which is why the silence feels alarming when it should feel expected.

Medically reviewed by Dr. Mohammed Imaduddin, Surgical Oncologist, MBBS · MS (General Surgery) · M.Ch (Surgical Oncology) · Last reviewed September 2026

A different kind of test — Molecular testing reads the DNA or protein markers inside your tumour, not just how the cells look.
The wait is built into the process — Multiple laboratory steps — none of which can be skipped — follow one another before a signed report exists.
Treatment need not always pause — Some treatments can begin on your standard biopsy result alone, without waiting for all molecular results.
Not all tests take the same time — Targeted tests for a single known change are faster than comprehensive panels. Which you need depends on your cancer type.

Book Free Consultation 1800 202 8726

4.8 · 800+ Google reviews · 15,000+ patients treated

17+

Cancer Specialists
on Panel

96.9%

Breast Cancer
Survival Rate*

15,000+

Patients
Treated

4.8★

Google Rating
(800+ reviews)

Molecular tests read the DNA or protein markers inside your tumour. They take considerably longer than the standard biopsy report, because the process involves multiple laboratory steps — extraction, sequencing, data analysis, and specialist review — that cannot be compressed. Most patients are not warned about this difference upfront.

What are the different types of tests run on your biopsy tissue?

Histopathology: The standard biopsy report. A pathologist examines the tissue under a microscope to confirm whether cancer is present, what type it is, and how the cells look. This is the first report your oncologist receives.
Immunohistochemistry (IHC): Checks for specific proteins on the surface of cancer cells using chemical dyes on the same tissue. Often done alongside histopathology and faster than gene sequencing.
PCR (Polymerase Chain Reaction): A targeted molecular method that tests for a small number of specific, known mutations. Faster than broad sequencing, and used when your oncologist is looking for one particular genetic change.
FISH (Fluorescence In Situ Hybridisation): Checks for specific gene rearrangements in tumour cells using fluorescent probes. Used for selected tumour types where a gene fusion is the key treatment-deciding change.
Next Generation Sequencing (NGS): Reads large sections of your tumour's DNA at once. It can identify hundreds of mutations, fusions, and other changes in a single run. The most comprehensive molecular test and also the one that takes the longest.
Turnaround time: The time from when the laboratory receives your sample to when a signed report is issued. It does not include transit time between the hospital and the testing laboratory, which adds to the total wait.

Why does molecular testing take so much longer than a standard biopsy report?

The standard biopsy report confirms cancer type by examining how cells appear under a microscope. Molecular testing goes further — it extracts genetic material from the tumour cells, amplifies it, runs it through a sequencing machine, and then processes the raw data through a computational pipeline. Each step must be completed correctly before the next can begin.

The tissue also has to pass quality checks before sequencing starts. If the sample is small, poorly preserved, or contains too few tumour cells, the laboratory may need to adjust the method — adding further time.

Finally, a molecular pathologist or genomics specialist must review and interpret the data before a signed clinical report is issued. That review is what turns a data readout into a result your oncologist can act on.

Can treatment start before all molecular results are back?

Yes, in many cases. Surgery, radiation, and some standard treatment regimens can begin on the basis of your histopathology report alone, without needing molecular results first.

Where molecular results are needed, your oncologist will distinguish between results that must be in before treatment starts and supplementary results that can come in during the first cycle. Ask them directly: which result is holding the decision, when is it expected, and is there anything appropriate to start in the meantime?

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile

Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile

Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile

Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile

Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile

Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile

Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile

Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile

Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile

Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile

Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile

Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile

Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile

Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile

Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile

Interventional Radiologist

Dr. Mohammed Imran

View Profile

Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile

Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

How different tests compare on speed and scope

Test type	What it reads	Relative speed	Common use
Histopathology	Cell shape and structure	Fastest	Confirming cancer type and grade
IHC	Specific proteins on cell surface	Fast	Receptor status and certain markers
PCR (targeted)	A few known specific mutations	Moderate	Checking for one expected genetic change
FISH	Specific gene rearrangements	Moderate	Selected gene fusions
NGS (comprehensive panel)	Hundreds of mutations and fusions	Slowest	Full biomarker profiling before treatment

Questions families ask about the wait

Can we ask for the results to be rushed?

Most molecular laboratories work through a standard processing queue and cannot fast-track individual samples without clinical justification. Your oncologist can contact the laboratory directly if there is an urgent clinical reason — for example, if one result is the only thing preventing treatment from starting. Ask your team whether that applies to your case rather than contacting the laboratory yourself.

What if the sample fails the quality check?

The laboratory will notify your oncology team if the sample is too small or too degraded to sequence reliably. A repeat biopsy or a liquid biopsy — where tumour DNA is extracted from a blood sample rather than tissue — may then be considered. Your oncologist will advise which is appropriate for your cancer type. This is not a common outcome, but it does happen and it adds further time to the wait.

Is a longer, more comprehensive test always better?

Not necessarily. If your oncologist is looking for one specific, well-understood genetic change, a faster targeted test may be more useful than waiting for a broad panel. The right test is the one that answers the clinical question quickly enough to be useful. Test selection belongs with your oncologist, not with a general recommendation about comprehensiveness.

What does 'no actionable mutation found' mean?

It means the test found no changes that currently have an approved matched treatment. It does not mean the test was wasted or that your cancer cannot be treated. Your oncologist will recommend the treatment that is indicated based on the full picture. Evidence in molecular oncology moves quickly, and a result that is not actionable today may become relevant as guidelines are updated.

Can we get the test done elsewhere to save time?

If your sample has already been sent to a laboratory, redirecting it usually does not save time and risks damage or delay in transit. Where a genuine second opinion on interpretation is needed — a borderline or unusual result — your oncologist can arrange for the report, not the raw sample, to be reviewed by a specialist at another centre.

Did you know?

Formalin — the chemical used to preserve your biopsy sample — fragments DNA. Molecular laboratories must compensate for this damage before sequencing, which is why the interval between tissue removal and fixation is a formal quality step in molecular pathology, not just a logistics detail.

Source: ESMO guidelines on biomarker testing and tissue handling

Explore 112 more Markers, Molecular Testing and Test Accuracy topics

Molecular & Genomic Testing

Breast Markers: ER, PR, HER2, Ki-67

False Negatives & Accuracy

IHC Markers Explained

Inadequate, Inconclusive & Repeat Biopsy

Labs, Slides, Blocks & Second Opinions

All Markers, Molecular Testing and Test Accuracy →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726

Common questions

Frequently asked questions

How long do molecular results actually take?

The honest answer is that it varies considerably by test type, laboratory, and how quickly your sample arrives. Histopathology confirming cancer type is the fastest. Molecular tests — especially comprehensive NGS panels — take considerably longer. ESMO and NCCN guidance both describe multi-step processing pipelines where sequencing, data analysis, and specialist review all take time that cannot be shortened. When the sample is sent, your oncology team should give you an expected date. If nobody has told you when to expect the result, that is the first question to ask.

Why wasn't I warned the wait would be this long?

Histopathology and molecular testing are often ordered at the same time from the same tissue block, which leads many patients to assume the reports will arrive together. They are entirely different laboratory processes with different timelines. Oncology teams sometimes underestimate how confusing this is for families who are already anxious. If you were not told, it was most likely an oversight in explaining the process, not a sign that something has gone wrong with your results.

What is the fastest molecular test available?

For checking a single specific mutation, PCR-based methods are the fastest molecular option. IHC, which tests for proteins rather than gene changes, is also relatively fast. Where your oncologist needs a broader picture, a comprehensive NGS panel is more informative but takes longer. Ask your team whether a targeted test can give the essential information before the full panel comes back — in some situations it can, and treatment can start sooner as a result.

My oncologist is waiting for one result before starting treatment — is that normal?

Yes. For certain cancers, one specific biomarker result determines whether a particular treatment is appropriate at all, and starting before that result is known would mean either guessing or giving a treatment that may not fit. Your oncologist is not being overly cautious — they are waiting for the information that makes the decision sound. If the wait feels very long, ask when the result is expected and whether any part of care can be advanced in the meantime.

Is there a single test that checks everything at once?

Comprehensive NGS panels come closest. They analyse large sections of tumour DNA in one run and can detect a wide range of mutations, fusions, and other changes. They do not replace IHC or FISH for the specific markers those methods read, and not every patient needs a comprehensive panel. Your oncologist selects the combination of tests that matches your cancer type and the specific clinical questions that need answering.

Is molecular testing available through CION?

Yes. CION coordinates molecular testing for patients across its centres and works with accredited partner laboratories. Testing is arranged from your biopsy sample, which is sent to the laboratory directly. CION does not own molecular testing laboratories; results come from partner facilities and are reviewed with you by your oncologist when they are ready. If you want to know where your sample was sent or when results are expected, ask the team at your treating centre.

Full index